J R Farndon

EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER

J Richard, Christopher Sainsbury, GeoffreyK. Needham et al. · The Lancet · 1987 · 877 citations

Tumor Biology, Breast Oncology, Medicine +8

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

C Wright, S Nicholson, Brian Angus et al. · British Journal of Cancer · 1992 · 380 citations · Full text

Advanced Breast Cancer, Breast Oncology, Medicine +8

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Mitch Dowsett, J. Houghton, Cecilie Riis Iden et al. · Annals of Oncology · 2006 · 267 citations · Full text

Her2 Status, Breast Oncology, Medicine +9

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.

J R C Sainsbury, A J Malcolm, David R. Appleton et al. · Journal of Clinical Pathology · 1985 · 226 citations · Full text

Richardson Score, Breast Oncology, Medicine +10

EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

S Nicholson, P. Halcrow, J R Farndon et al. · The Lancet · 1989 · 218 citations

Breast Oncology, Cancer Growth, Pathology +6